An interventional study of Airbag Belt Fall Protection System in Stroke, Parkinson Disease and Lower Limb Amputation Knee, sponsored by Shirley Ryan AbilityLab. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-29.
Sponsored by Shirley Ryan AbilityLab · Not applicable, Interventional, and Device feasibility
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 64 studies in Stroke by Shirley Ryan AbilityLab — 12 open to participants now, 20 under way, none of them phase 3. Stroke · Shirley Ryan AbilityLab.
Among the 64 studies in Stroke by Shirley Ryan AbilityLab, this one is the 2nd largest by planned enrollment of the 55 interventional ones that give a count, is one of 3 that started in 2018, is one of 49 with no phase, reaches primary completion later than 9 of the 19 other live ones, and was the 42nd registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →12 of the 64 studies in Stroke by Shirley Ryan AbilityLab are open now, in 1 country. Recruiting first, the newest first:
Shirley Ryan AbilityLab · Sites in United States
Ages 18+
Shirley Ryan AbilityLab · Sites in United States
Ages 40–70 · Healthy volunteers
Shirley Ryan AbilityLab · Sites in United States
Ages 18+ · Healthy volunteers
Shirley Ryan AbilityLab · Sites in United States
Ages 18+
Shirley Ryan AbilityLab · Sites in United States
Ages 18–89
By country, each count listing its studies:
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 18 Years to 85 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
64 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 2 · Phase 3 2
First in 2003; this study’s year is marked. 3 started in 2018.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 200 is above the median of 48 across 6,049 interventional studies indexed under Stroke.
Median enrollment 30 across the 55 interventional studies, 40 across the 9 observational. Of the 32 that completed or were terminated, 12 (38%) have results posted.
This tab as a report to print or save as PDF → With an account.
Shirley Ryan AbilityLab is the lead sponsor of 181 studies on the registry; 44 are open to participants now.
Of its 10 completed or terminated interventional studies of FDA-regulated products, 4 (40%) have results posted.
7 of the studies in Stroke by Shirley Ryan AbilityLab that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03300141Shirley Ryan AbilityLabLooking Glass: Bimanual Balanced Reaching With Visual Biofeedback | 2026-12 |
| NCT05076565Shirley Ryan AbilityLabWearable Airbag Technology to Mitigate Falls in Individuals With High Fall Risk | 2026-12-14 |
| NCT05471375Shirley Ryan AbilityLabC-STAR Movement Database | 2026-12-31 |
| NCT06234124Shirley Ryan AbilityLabCharacterization and Clinical Trial of a Variable Friction Shoe | 2027-01 |
| NCT06663501Shirley Ryan AbilityLabEffects of Vibration on Motor Function of Survivors of Chronic Stroke | 2027-03-01 |
Add all 7 to your calendar (.ics) → With an account.
Among the 64 studies in Stroke by Shirley Ryan AbilityLab, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to evaluate the feasibility and efficacy of a smart airbag system that detects and mitigates fall-related impact in individuals with high fall risk.
The purpose of this study is to evaluate the feasibility and efficacy of a smart airbag system that detects and mitigates fall-related impact in individuals with high fall risk.
The specific aims of this study are:
The investigators hypothesize that a soft, smart airbag system that uses advanced machine learning algorithms can accurately detect and mitigate falls, deploying appropriately to reduce hip fractures due to falls. The investigators also expect that wearing this device will decrease fear of falling and thus increase community mobility and social interaction.
INCLUSION AND EXCLUSION CRITERIA
All potential subjects will be evaluated by research staff in order to match them to the inclusion and exclusion criteria that has been established - see below:
Inclusion Criteria - Able bodied Subjects:
Exlusion Criteria - Able bodied Subjects:
Inclusion Criteria - Fall Risk Subjects:
Exclusion Criteria - Fall Risk Subjects
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Both versions of Airbags features different number of IMU sensors. Participant's will be randomly assigned one of the two versions. The algorithms developed in this project will help the researcher to identify the optimal performance (sensitivity and specificity values for detecting falls). Based on this information the research team will be able to choose a version for home/community deployment portion of the study. Based on the performance of the airbags in detecting true positives (falls) and true negatives (non-falls) accurately one of the airbags will be used in community deployment phase of the study.
Pre-fall classification performance
Derivation(s) from a confusion matrix
Time frame: 1 year
Plan to share: No
Started Jan 2018 (actual). Primary completion is estimated for Dec 2026, 107 months after the start.
Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 107 months is above that.
Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.